Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v6-EN
Language French English
Date Updated 2017-10-18 2017-03-15
Drug Identification Number 02398427 02398427
Brand name METHOTREXATE INJECTION USP METHOTREXATE INJECTION USP
Common or Proper name METHOTREXATE METHOTREXATE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients METHOTREXATE METHOTREXATE
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS
Packaging size 2mL fiole/vial 2mL fiole/vial
ATC code L01BA L01BA
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2017-03-14 2017-03-14
Actual start date
Estimated end date 2017-08-28 2017-03-20
Actual end date 2017-08-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Available in 20mL format Available in 20mL format
Health Canada comments